Megan Doheny
Women's Health · Hobart, INNPI 1609318922
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.1% of the total across 68 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by AbbVie at 24.5% of the total. Reporting peaked in 2021 at $465 and has fallen 52.1% since, to $223 in 2025.
Across 68 payments — averaging $18.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$300
- Astellas Pharma US Inc$165
- Exact Sciences$106
- Sumitomo Pharma America, Inc.$91
- Pfizer$80
- Bayer$79
- plus $406 from 11 others
What the payments were for
- Food & beverage$1,14293%
- Education$857%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 23 | $300 |
| Astellas Pharma US Inc | 5 | $165 |
| Exact Sciences | 5 | $106 |
| Sumitomo Pharma America, Inc. | 5 | $91 |
| Pfizer | 4 | $80 |
| Bayer | 4 | $79 |
| Coloplast | 1 | $58 |
| Organon | 4 | $56 |
| Smith+Nephew | 3 | $53 |
| Mayne Pharma Commercial LLC | 3 | $50 |
| Myovant Sciences Inc. | 3 | $48 |
| Exeltis, USA Inc. | 2 | $33 |
| Dysis Medical, Inc. | 2 | $32 |
| Agile Therapeutics, Inc. | 1 | $24 |
| Avion Pharmaceuticals | 1 | $19 |
| Meditrina | 1 | $18 |
| Biogen | 1 | $15 |
How this compares
$1,227 in reported general payments places this provider in the 80th percentile of 142 women's health providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other women's health in Hobart
- Cara RaunickIndianapolis$73K
- Debra TaylorGreenwood$33K
- Elizabeth FourmanNotre Dame$15K
- Amanda NakashianDyer$8K
- Courtney CortezIndianapolis$5K
- Natasha StruewingGreensburg$5K
- Rebecca PapamihalakisMunster$4K
- Kesha KellyIndianapolis$4K
- Amanda PhelpsEvansville$4K
- Taylor JohnsonNoblesville$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.